Abstract

Background The clinical management of bacterial infection computes factors related to bacteria (e.g., resistance profile [1]), antibiotics (e.g., activity spectrum, distribution volume, etc.), host characteristics (e.g., vascularization of the infected tissue, effectiveness of host defenses, etc.), as well as pharmacokinetic (PK) parameters [2]. The serum inhibitory (SIT) and bactericidal titers (SBT) are laboratory tests that simulate the interactions between antibiotics and bacteria in the human body milieu.

Highlights

  • The clinical management of bacterial infection computes factors related to bacteria, antibiotics, host characteristics, as well as pharmacokinetic (PK) parameters [2]

  • The strains had been isolated from blood cultures (49.4%), cutaneous wounds (23.6%), tracheal aspirate (13.5%) and urine samples (7.9%)

  • serum inhibitory (SIT) ranged from 1/2 (12.4%) to 1/512 (5.6%), but only in 20 cases (22.4%) the titers were in the therapeutic comfort range of 1/64 to 1/512

Read more

Summary

Background

The clinical management of bacterial infection computes factors related to bacteria (e.g., resistance profile [1]), antibiotics (e.g., activity spectrum, distribution volume, etc.), host characteristics (e.g., vascularization of the infected tissue, effectiveness of host defenses, etc.), as well as pharmacokinetic (PK) parameters [2]. The serum inhibitory (SIT) and bactericidal titers (SBT) are laboratory tests that simulate the interactions between antibiotics and bacteria in the human body milieu

Methods
Results
Streinu-Cercel O
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.